Eloxx Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $24.0M | $2.2M | $1.4M | $1.7M | $1.6M | $2.0M | $3.6M |
| Accounts Receivable | — | — | $0 | $43.1K | $0 | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $24.5M | $3.1M | $3.7M | $7.2M | $3.5M | $3.5M | $5.1M |
| Property, Plant & Equipment | $278.0K | $41.0K | $185.9K | $223.5K | $4.6K | $5.9K | $3.8K |
| Goodwill | — | $0 | $5.8M | $13.9M | $0 | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $0 | $2.2M | $3.6M | $3.4M | $3.5M |
| Total Assets | $24.8M | $3.1M | $19.5M | $33.3M | $7.1M | $7.0M | $8.6M |
| Liabilities | |||||||
| Accounts Payable | $1.5M | $1.9M | $232.0K | $901.2K | $637.3K | $594.5K | $559.5K |
| Total Current Liabilities | $3.4M | $2.5M | $778.5K | $1.8M | $3.2M | $3.2M | $3.3M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $5.0M | $4.7M | $7.3M | $5.8M | $3.3M | $3.5M | $4.1M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-39.0M | $-17.7M | $-107.2M | — | — | — | — |
| Total Stockholders' Equity | $21.4M | $610.0K | $643.0K | $2.8M | $3.8M | $3.5M | $4.5M |